
World | FOCUS Feb 5, 2022
Inside Johnson & Johnson’s secret plan to cap litigation payouts to cancer victims
If J&J succeeds, some experts argue, it could provide a blueprint for corporate America on how to circumvent jury trials involving allegations of defective products or misconduct.